Copy to clipboard 
MCRA continues to grow its Reimbursement, Health Economics and Market Access (RHEMA) Division through the hiring of John D. McDermott, Jr., MBA, as Senior Director, Reimbursement Strategy.
Mr. McDermott brings 30 years of comprehensive industry experience that spans the major segments of market access, reimbursement, coverage access programs and health economics and outcomes research. He has developed and executed reimbursement strategies for hundreds of companies, including more than 20 successful commercial technology launches. His experience includes the development of revenue forecasts, recommending launch prices, guiding clinical protocol design for maximal commercial impact and helping companies articulate the value and market potential of their products to assist with seeking new rounds of funding. He has published evidence to support commercialization, served as study director for observational studies, created budget impact models and selected health economic and patient reported outcomes endpoints.
He has broad experience in covering medical devices, pharmaceuticals and biologics.
Tonya Dowd, MCRA’s Vice President of RHEMA, said, “I have always believed that clients are best served by an integrated approach to product development and commercialization. John’s strong technical reimbursement expertise and his broad experience understanding the evidence needs of stakeholders make him a perfect fit for our growing RHEMA team as we pursue our vision of delivering integrated reimbursement, regulatory, and clinical solutions to our current and future clients.”
